Redefining the Target Again: Chemotherapeutics as Vascular Disrupting Agents?
نویسندگان
چکیده
منابع مشابه
Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
It is widely known that angiogenesis plays a key role in endometriotic lesion formation and development. Antiangiogenic treatments aimed at inhibiting new vessel formation have proven efficient in experimental models. However, as antiangiogenic strategies do not target pre-existing pericyte-protected vessels, they require chronic administration and are likely to be beneficial for early-stage di...
متن کاملTumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions
The emergence of vascular disrupting agents (VDAs) is a significant advance in the treatment of solid tumors. VDAs induce rapid and selective shutdown of tumor blood flow resulting in massive necrosis. However, a viable marginal tumor rim always remains after VDA treatment and is a major cause of recurrence. In this review, we discuss the mechanisms involved in the resistance of solid tumors to...
متن کاملTaking down tumors: vascular disrupting agents entering clinical trials.
A tumor's support system — its existing blood vessels, or vasculature — nourishes the tumor by supplying oxygen and nutrients, allowing it to grow, spread, and often turn lethal. Antiangiogenesis approaches attempt to prevent the formation of these blood vessels, but researchers are also focused on targeting the established vasculature in hopes of destroying tumors by obliterating the blood ves...
متن کاملEvaluation of a 99mTc-tricine Vascular Disrupting Agent as an In-vivo Imaging in 4T1 Mouse Breast Tumor Model
Colchicine as a vascular disrupting agent creates microtubule destabilization whichinduces vessel blockage and consequently cell death. Accordingly, colchicines and itsanalogues radiolabeled with 99mTc may have potential for visualization of tumor. In this work,deacetylcolchicine a colchicine analogue was labeled with 99mTc via tricine as a coligandand characterized for its tumor targeting prop...
متن کاملAnticancer potential of tumor vascular disrupting agents: review of the latest clinical evidence
Solid tumors differ from normal tissue by having a low vascular density, leading to various forms of vascular stress. Tumor vascular disrupting agents (VDAs) act to potentiate this stress, increasing vascular permeability and decreasing blood flow. Two main classes of tumor VDAs have progressed so far to clinical trial: the ‘flavonoid’ class, represented by vadimezan, and the tubulin poisons, r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Cell
سال: 2008
ISSN: 1535-6108
DOI: 10.1016/j.ccr.2008.08.006